An approach to the site-selective diversification of apoptolidin A with peptide-based catalysts

Journal of Natural Products

Volumn 72, Issue 10, 2009, Pages 1864-1869

  Lewis, Chad A ^a   Longcore, Kate E ^b   Miller, Scott J ^a   Wender, Paul A ^b  

^a YALE UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE DERIVATIVE; ANTINEOPLASTIC AGENT; APOPTOLIDIN A; N,N DIMETHYL 4 AMINOPYRIDINE; PEPTIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CATALYST; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; DRUG SELECTIVITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; SCREENING TEST;

APOPTOSIS; CATALYSIS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MACROLIDES; MOLECULAR STRUCTURE; PEPTIDES;

EID: 70350491037     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np9004932     Document Type: Article

References (39)

1. (a) Kim, J. W.; Adachi, H.; Shin-ya, K.; Hayakawa, Y.; Seto, H. J. Antibiot. 1997, 50, 628-630.
2. (b) Hayakawa, Y.; Kim, J. W.; Adachi, H.; Shin-ya, K.; Fujita, K.; Seto, H. J. Am. Chem. Soc. 1998, 120, 3524-3525.
3. For a review including early synthetic work by Nicolaou et al., Sulikowski et al., and Koert, et al., see: Daniel, P. T.; Koert, U.; Schuppan, J. Angew. Chem., Int. Ed. 2006, 45, 872-893, and references therein.
4. For more recent synthetic work see: (a) Wehlan, H.; Dauber, M.; Mujica Fernaud, M. T.; Schuppan, J.; Keiper, S.; Mahrwald, R.; Juarez Garcia, M.-E.; Koert, U. Chem.-Eur. J. 2006, 12, 7378-7397.
5. (b) Crimmins, M. T.; Christie, H. S.; Long, A.; Chaudhary, K. Org. Lett. 2009, 11, 831-834.
6. (c) Schuppan, J.; Wehlan, H.; Keiper, S.; Koert, U. Chem.-Eur. J. 2006, 12, 7364-7377.
7. (d) Ghidu, V. P.; Wang, J.; Wu, B.; Liu, Q.; Jacobs, A.; Marnett, L. J.; Sulikowski, G. A. J. Org. Chem. 2008, 73, 4949-4955.
8. (e) Chng, S.-S.; Xu, J.; Loh, T. P. Tetrahedron Lett. 2003, 44, 4997-5000.
9. (f) Bouchez, L. C.; Vogel, P. Chem.-Eur. J. 2005, 11, 4609-4620.
10. (g) Wu, B.; Liu, Q.; Jin, B.; Qu, T.; Sulikowski, G. A. Eur. J. Org. Chem. 2006, 277-284.
11. (h) Kim, Y.; Fuchs, P. L. Org. Lett. 2007, 9, 2445-2448.
12. (i) Craita, C.; Didier, C.; Vogel, P. Chem. Commun. 2007, 23, 2411-2413.
13. (j) Handa, M.; Scheidt, K. A.; Bossart, M.; Zheng, N.; Roush, W. R. J. Org. Chem. 2008, 73, 1031-1035.
14. (k) Handa, M.; Smith, W. J., III.; Roush, W. R. J. Org. Chem. 2008, 73, 1036-1039.
15. (l) Ghidu, V. P.; Ntai, I.; Wang, J.; Jacobs, A. T.; Marnett, L. J.; Bachmann, B. O.; Sulikowski, G. A. Org. Lett. 2009, 11, 3032-3034.
16. (a) Salomon, A. R.; Zhang, Y.; Seto, H.; Khosla, C. Org. Lett. 2001, 3, 57-59.
17. (b) Wender, P. A.; Gulledge, A. V.; Jankowski, O. D.; Seto, H. Org. Lett. 2002, 4, 3819-3822.
18. (c) Pennington, J. D.; Williams, H. J.; Salomon, A. R.; Sulikowski, G. A. Org. Lett. 2002, 4, 3823-3825.
19. (d) Wender, P. A.; Jankowski, O. D.; Tabet, E. A.; Seto, H. Org. Lett. 2003, 5, 487-490.
20. (e) Wender, P. A.; Jankowski, O. D.; Tabet, E. A.; Seto, H. Org. Lett. 2003, 5, 2299-2302.
21. (f) Wender, P. A.; Jankowski, O. D.; Longcore, K.; Tabet, E. A.; Seto, H.; Tomikawa, T. Org. Lett. 2006, 8, 589-592.
22. (a) Wender, P. A.; Sukopp, M.; Longcore, K. Org. Lett. 2005, 7, 3025-3028.
23. (b) Wender, P. A.; Longcore, K. E. Org. Lett. 2007, 9, 691-694.
24. (a) Abel, U.; Koch, C.; Speitling, M.; Hansske, F. G. Curr. Opin. Chem. Biol. 2002, 6, 453-458.
25. (b) Riva, S. Curr. Opin. Chem. Biol. 2001, 5, 106-111.
26. Lewis, C. A.; Miller, S. J. Angew. Chem., Int. Ed. 2006, 45, 5616-5619.
27. Lewis, C. A.; Merkel, J.; Miller, S. J. Bioorg. Med. Chem. Lett. 2008, 18, 6007-6011.
28. Miller, S. J.; Clardy, J. Nat. Chem. 2009, 1, 261-263.
29. Existing peptide libraries from previous projects were screened initially. See, for example: (a) Jarvo, E. R.; Copeland, G. T.; Papaioannou, N.; Bonitatebus, P. J., Jr.; Miller, S. J. J. Am. Chem. Soc. 1999, 121, 11638-11643.
30. (b) Sculimbrene, B. R.; Morgan, A. J.; Miller, S. J. J. Am. Chem. Soc. 2002, 124, 11653-11656.
31. (c) Lewis, C. A.; Sculimbrene, B. R.; Xu, Y.; Miller, S. J. Org. Lett. 2005, 7, 3021- 3023.
32. (d) Evans, J. W.; Fierman, M. B.; Miller, S. J.; Ellman, J. A. J. Am. Chem. Soc. 2004, 126, 8134-8135.
33. (e) Lewis, C. A.; Chiu, A.; Kubryk, M.; Balsells, J.; Pollard, D.; Esser, C. K.; Murry, J.; Reamer, R. A.; Hansen, K. B.; Miller, S. J. J. Am. Chem. Soc. 2006, 128, 16454-16455.
34. See Supporting Information for details.
35. (a) Salomon, A. R.; Voehringer, D. W.; Herzenberg, L. A.; Khosla, C. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 14766-14771.
36. (b) Salomon, A. R.; Voehringer, D. W.; Herzenberg, L. A.; Khosla, C. Chem. Biol. 2001, 8, 71-80.
37. (a) Wender, P. A.; Verma, V. A.; Paxton, T. J.; Pillow, T. H. Acc. Chem. Res. 2007, 41, 40-49.
38. (b) Wender, P. A.; Miller, B. L. Nature 2009, 460, 197-201.
39. Mosmann, T. J. Immunol. Methods 1983, 65, 55-63.